You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metronomic cyclophosphamide

Showing 1 - 25 of 2,027
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

Recruiting
  • Ependymoma
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
Dec 16, 2022

Neuroendocrine Tumors Trial in Besancon, Montbéliard (Metronomic cyclophosphamide, Interferon-alpha)

Completed
  • Neuroendocrine Tumors
  • Besancon, France
  • +1 more
Jul 30, 2021

Recurrent Endometrial Cancer Trial in France (Olaparib, metformin, metronomic cyclophosphamide)

Completed
  • Recurrent Endometrial Cancer
  • Caen, France
  • +5 more
Dec 6, 2021

Solid Tumors, Soft-tissue Sarcoma, Breast Cancer Trial in Bordeaux (Cyclophosphamide and JX-594 dose escalation,

Recruiting
  • Solid Tumors
  • +2 more
  • Cyclophosphamide and JX-594 dose escalation
  • +3 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Multiple Myeloma Trial in Pawtucket, Providence (Ixazomib, Cyclophosphamide, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Pawtucket, Rhode Island
  • +2 more
Jul 21, 2022

Metastatic Colorectal Cancer Trial in France (other, procedure, drug)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • quality of life questionnaires
  • +6 more
  • Besançon, France
  • +6 more
Jul 15, 2022

Soft-tissue Sarcomas Trial in Bordeaux (Phase 1: Trabectedin, Phase 2: Trabectedin, Phase 1: Cyclophosphamide)

Active, not recruiting
  • Soft-tissue Sarcomas
  • Phase 1: Trabectedin
  • +3 more
  • Bordeaux, France
    Institut Bergonié
May 4, 2021

Soft Tissue Sarcoma Adult Trial in Italy (Cyclophosphamide, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • Bologna, BO, Italy
  • +12 more
Mar 31, 2022

Sarcoma Trial in France (Combination of MK3475 with Metronomic CP, Combination of MK3475 with Metronomic CP and G100)

Active, not recruiting
  • Sarcoma
  • Combination of MK3475 with Metronomic CP
  • Combination of MK3475 with Metronomic CP and G100
  • Bordeaux, France
  • +7 more
May 4, 2021

Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Trial run by the NCI

Terminated
Has Results
  • Thoracic Sarcomas
  • +4 more
  • H1299 cell lysates
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 27, 2021

Childhood Solid Tumor Trial in Belgium, France (Vinblastine, Cyclophosphamide, Capecitabine)

Recruiting
  • Childhood Solid Tumor
  • Brussel, Belgium
  • +10 more
May 27, 2022

Breast Cancer Trial in Guangzhou (Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI)

Recruiting
  • Breast Cancer
  • Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus AI
  • Guangzhou, Guangdong, China
    Shusen Wang
Jul 1, 2021

Solid Tumor, Osteosarcoma Trial in Bordeaux, Lille, Lyon (Sirolimus combined with CP, MT and ZA)

Recruiting
  • Solid Tumor
  • Osteosarcoma
  • Sirolimus combined with CP, MT and ZA
  • Bordeaux, France
  • +2 more
May 4, 2021

Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

Active, not recruiting
  • Neuroblastoma
  • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
  • Cytoxan
  • Houston, Texas
    Texas Children's Hospital
Mar 25, 2022

Metastatic Breast Cancer Trial in Beijing (Vinorelbine 40mg, Toripalimab 240mg, Bevacizumab 5 mg/kg)

Recruiting
  • Metastatic Breast Cancer
  • Vinorelbine 40mg
  • +5 more
  • Beijing, Beijing, China
  • +1 more
Feb 9, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

Recruiting
  • Glioma
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 22, 2021

Breast Cancer Trial in Italy (Paclitaxel, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Aviano, Italy
  • +19 more
Aug 31, 2022

Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

Recruiting
  • Solid Tumor
  • Atlanta, Georgia
  • +4 more
Feb 8, 2022

Breast Cancer Trial in United States (Bevacizumab, Cyclophosphamide, Methotrexate)

Terminated
Has Results
  • Breast Cancer
  • Birmingham, Alabama
  • +8 more
Dec 20, 2021

Cancer Trial in United States (Sirolimus, Celecoxib, Etoposide)

Recruiting
  • Cancer
  • Phoenix, Arizona
  • +5 more
Oct 28, 2021

Aggressive Non-Hodgkin Lymphoma Trial in Italy (Prednisone, Vinorelbine, Etoposide)

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • Brescia, Italy
  • +9 more
Dec 17, 2021

Breast Cancer Trial in Greenville (drug, procedure, radiation)

Terminated
Has Results
  • Breast Cancer
  • Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin
  • +2 more
  • Greenville, North Carolina
    Brody School of Medicine at East Carolina University
May 4, 2021

Advanced Breast Cancer Trial in Milan (Vinorelbine, Capecitabine, Cyclophosphamide)

Unknown status
  • Advanced Breast Cancer
  • Milan, Italy
    European Institute of Oncology
Apr 24, 2020